XTX Topco’s Vor Biopharma VOR Stock Holding History

XTX Topco’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.52M	Buy	+82,645	New	+$1.25M	0.02%	1382
2026 Q1	–	Sell	-17,542	Closed	-$229K	–	4438
2025 Q4	$229K	Buy	+17,542	New	+$327K	0.01%	2292
2025 Q3	–	Sell	-2,047	Closed	-$66.3K	–	3338
2025 Q2	$66.3K	Buy	+2,047	New	+$18.1K	﹤0.01%	1966
2025 Q1	–	Sell	-3,589	Closed	-$79.7K	–	3174
2024 Q4	$79.7K	Buy	+3,589	New	+$59.5K	0.01%	1814
2024 Q2	–	Sell	-932	Closed	-$44.2K	–	2509
2024 Q1	$44.2K	Buy	+932	New	+$40.9K	0.01%	1487

Other funds holding VOR

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

XTX Topco's VOR Position: Q2 2026 in Review

XTX Topco opened a new position in Vor Biopharma (VOR) in Q2 2026: 82,645 shares worth $1.52M. The stake represents 0.02% of the portfolio and ranks #1382 among its holdings. This is a return to the name: XTX Topco previously reported a position in VOR as recently as Q4 2025.

XTX Topco first reported a position in VOR in Q1 2024 and has held it in 5 quarters since. 102 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

XTX Topco held 82,645 shares of Vor Biopharma worth $1.52M as of Q2 2026.
Vor Biopharma was a new XTX Topco position in Q2 2026.
Vor Biopharma made up 0.02% of XTX Topco's portfolio in Q2 2026, its #1382 holding.
XTX Topco first reported a position in Vor Biopharma in Q1 2024 and has held it in 5 quarters since.
102 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.